Martino Martinelli-Filho, MD, PhD; José A. Marin-Neto, MD, PhD; Mauricio Ibrahim Scanavacca, MD, PhD; et al.
open access
JAMA Cardiol. Published online October 2, 2024. doi:10.1001/jamacardio.2024.3169
This randomized clinical trial assesses whether cardioverter-defibrillator implantation is more effective than amiodarone therapy for the primary prevention of all-cause mortality and secondary prevention of sudden cardiac death, hospitalization for heart failure, and use of a pacemaker among patients with chronic Chagas cardiomyopathy.
Marat Fudim, MD, MHS; Barry A. Borlaug, MD; Rajeev C. Mohan, MD; et al.
JAMA Cardiol. Published online October 2, 2024. doi:10.1001/jamacardio.2024.2612
This randomized clinical trial investigates the feasibility, safety, and efficacy of endovascular right-sided splanchnic nerve ablation for volume management in heart failure with preserved ejection fraction (HFpEF).